TY - JOUR AU - Barnes, R. A. PY - 2008 DA - 2008// TI - Early diagnosis of fungal infection in immunocompromised patients JO - J Antimicrob Chemother VL - 61 UR - https://doi.org/10.1093/jac/dkm424 DO - 10.1093/jac/dkm424 ID - Barnes2008 ER - TY - JOUR AU - Pfaller, M. A. AU - Messer, S. A. AU - Woosley, L. N. AU - Jones, R. N. AU - Castanheira, M. PY - 2013 DA - 2013// TI - Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance JO - J Clin Microbiol VL - 51 UR - https://doi.org/10.1128/JCM.00308-13 DO - 10.1128/JCM.00308-13 ID - Pfaller2013 ER - TY - JOUR AU - Kontoyiannis, D. P. AU - Marr, K. A. AU - Park, B. J. AU - Alexander, B. D. AU - Anaissie, E. J. AU - Walsh, T. J. AU - Ito, J. AU - Andes, D. R. AU - Baddley, J. W. AU - Brown, J. M. PY - 2010 DA - 2010// TI - Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database JO - Clin Infect Dis VL - 50 UR - https://doi.org/10.1086/651263 DO - 10.1086/651263 ID - Kontoyiannis2010 ER - TY - JOUR AU - Pagano, L. AU - Caira, M. AU - Candoni, A. AU - Offidani, M. AU - Martino, B. AU - Specchia, G. AU - Pastore, D. AU - Stanzani, M. AU - Cattaneo, C. AU - Fanci, R. PY - 2010 DA - 2010// TI - Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study JO - Haematologica VL - 95 UR - https://doi.org/10.3324/haematol.2009.012054 DO - 10.3324/haematol.2009.012054 ID - Pagano2010 ER - TY - JOUR AU - Walsh, T. J. AU - Petraitis, V. AU - Petraitiene, R. AU - Field-Ridley, A. AU - Sutton, D. AU - Ghannoum, M. AU - Sein, T. AU - Schaufele, R. AU - Peter, J. AU - Bacher, J. PY - 2003 DA - 2003// TI - Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B JO - J Infect Dis VL - 188 UR - https://doi.org/10.1086/377210 DO - 10.1086/377210 ID - Walsh2003 ER - TY - JOUR AU - Falcone, M. AU - Massetti, A. P. AU - Russo, A. AU - Vullo, V. AU - Venditti, M. PY - 2011 DA - 2011// TI - Invasive aspergillosis in patients with liver disease JO - Med Mycol VL - 49 UR - https://doi.org/10.3109/13693786.2010.535030 DO - 10.3109/13693786.2010.535030 ID - Falcone2011 ER - TY - JOUR AU - Patterson, T. F. AU - Thompson, G. R. AU - Denning, D. W. AU - Fishman, J. A. AU - Hadley, S. AU - Herbrecht, R. AU - Kontoyiannis, D. P. AU - Marr, K. A. AU - Morrison, V. A. AU - Nguyen, M. H. PY - 2016 DA - 2016// TI - Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America JO - Clin Infect Dis VL - 63 UR - https://doi.org/10.1093/cid/ciw444 DO - 10.1093/cid/ciw444 ID - Patterson2016 ER - TY - JOUR AU - Espinel-Ingroff, A. AU - Diekema, D. J. AU - Fothergill, A. AU - Johnson, E. AU - Pelaez, T. AU - Pfaller, M. A. AU - Rinaldi, M. G. AU - Canton, E. AU - Turnidge, J. PY - 2010 DA - 2010// TI - Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document) JO - J Clin Microbiol VL - 48 UR - https://doi.org/10.1128/JCM.00536-10 DO - 10.1128/JCM.00536-10 ID - Espinel-Ingroff2010 ER - TY - JOUR AU - Ashbee, H. R. AU - Barnes, R. A. AU - Johnson, E. M. AU - Richardson, M. D. AU - Gorton, R. AU - Hope, W. W. PY - 2014 DA - 2014// TI - Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology JO - J Antimicrob Chemother VL - 69 UR - https://doi.org/10.1093/jac/dkt508 DO - 10.1093/jac/dkt508 ID - Ashbee2014 ER - TY - JOUR AU - Roberts, D. J. AU - Hall, R. I. PY - 2013 DA - 2013// TI - Drug absorption, distribution, metabolism and excretion considerations in critically ill adults JO - Expert Opin Drug Metab Toxicol VL - 9 ID - Roberts2013 ER - TY - STD TI - US Food and Drug Administration Antiviral Drugs Advisory Committee. Briefing document for voriconazole (oral and intravenous formulations). 2001. http://www.fda.gov/ohrms/dockets/ac/01/briefing/3792b2_01_Pfizer.pdf. UR - http://www.fda.gov/ohrms/dockets/ac/01/briefing/3792b2_01_Pfizer.pdf ID - ref11 ER - TY - STD TI - Noxafil® (posaconazole) injection, delayed-release tablets, oral suspension [prescribing information]. Merck & Co., Inc., Whitehouse Station, NJ; 2014. http://www.merck.com/product/usa/pi_circulars/n/noxafil/noxafil_pi.pdf. UR - http://www.merck.com/product/usa/pi_circulars/n/noxafil/noxafil_pi.pdf ID - ref12 ER - TY - JOUR AU - Alvarez-Lerma, F. AU - Allepuz-Palau, A. AU - Garcia, M. P. AU - Angeles Leon, M. AU - Navarro, A. AU - Sanchez-Ruiz, H. AU - Iruretagoyena, J. R. AU - Luque-Gomez, P. PY - 2008 DA - 2008// TI - Voriconazole Study Group in Critically Ill P: Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function JO - J Chemother VL - 20 UR - https://doi.org/10.1179/joc.2008.20.1.93 DO - 10.1179/joc.2008.20.1.93 ID - Alvarez-Lerma2008 ER - TY - JOUR AU - Laverdiere, M. AU - Bow, E. J. AU - Rotstein, C. AU - Autmizguine, J. AU - Broady, R. AU - Garber, G. AU - Haider, S. AU - Hussaini, T. AU - Husain, S. AU - Ovetchkine, P. PY - 2014 DA - 2014// TI - Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective JO - Can J Infect Dis Med Microbiol VL - 25 ID - Laverdiere2014 ER - TY - JOUR AU - Meletiadis, J. AU - Mavridou, E. AU - Melchers, W. J. AU - Mouton, J. W. AU - Verweij, P. E. PY - 2012 DA - 2012// TI - Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.05959-11 DO - 10.1128/AAC.05959-11 ID - Meletiadis2012 ER - TY - STD TI - U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Bio-analytical Method Validation. Rockville, MD; 2001. http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf. UR - http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf ID - ref16 ER - TY - JOUR AU - Hachem, R. AU - Gomes, M. Z. AU - Helou, G. AU - Zakhem, A. AU - Kassis, C. AU - Ramos, E. AU - Jiang, Y. AU - Chaftari, A. M. AU - Raad, I. I. PY - 2014 DA - 2014// TI - Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy JO - J Antimicrob Chemother VL - 69 UR - https://doi.org/10.1093/jac/dku241 DO - 10.1093/jac/dku241 ID - Hachem2014 ER - TY - JOUR AU - Steinbach, W. J. AU - Benjamin, D. K. AU - Kontoyiannis, D. P. AU - Perfect, J. R. AU - Lutsar, I. AU - Marr, K. A. AU - Lionakis, M. S. AU - Torres, H. A. AU - Jafri, H. AU - Walsh, T. J. PY - 2004 DA - 2004// TI - Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/421950 DO - 10.1086/421950 ID - Steinbach2004 ER - TY - JOUR AU - Moton, A. AU - Krishna, G. AU - Ma, L. AU - O'Mara, E. AU - Prasad, P. AU - McLeod, J. AU - Preston, R. A. PY - 2010 DA - 2010// TI - Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007990903364657 DO - 10.1185/03007990903364657 ID - Moton2010 ER - TY - STD TI - VFEND® (voriconazole) Product Monograph. Kirkland, QC: Pfizer Canada, Inc.; 2016. https://www.pfizer.ca/sites/g/files/g10028126/f/201605/VFEND_PM_E_187649_26_Jan_2016.pdf. UR - https://www.pfizer.ca/sites/g/files/g10028126/f/201605/VFEND_PM_E_187649_26_Jan_2016.pdf ID - ref20 ER - TY - JOUR AU - Luke, D. R. AU - Tomaszewski, K. AU - Damle, B. AU - Schlamm, H. T. PY - 2010 DA - 2010// TI - Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD) JO - J Pharm Sci VL - 99 UR - https://doi.org/10.1002/jps.22109 DO - 10.1002/jps.22109 ID - Luke2010 ER - TY - JOUR AU - Walsh, T. J. AU - Raad, I. AU - Patterson, T. F. AU - Chandrasekar, P. AU - Donowitz, G. R. AU - Graybill, R. AU - Greene, R. E. AU - Hachem, R. AU - Hadley, S. AU - Herbrecht, R. PY - 2007 DA - 2007// TI - Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/508774 DO - 10.1086/508774 ID - Walsh2007 ER - TY - JOUR AU - Andes, D. AU - Pascual, A. AU - Marchetti, O. PY - 2009 DA - 2009// TI - Antifungal therapeutic drug monitoring: established and emerging indications JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.00705-08 DO - 10.1128/AAC.00705-08 ID - Andes2009 ER - TY - JOUR AU - Dolton, M. J. AU - Ray, J. E. AU - Marriott, D. AU - McLachlan, A. J. PY - 2012 DA - 2012// TI - Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.05900-11 DO - 10.1128/AAC.05900-11 ID - Dolton2012 ER - TY - JOUR AU - Casadevall, A. AU - Pirofski, L. A. PY - 2001 DA - 2001// TI - Adjunctive immune therapy for fungal infections JO - Clin Infect Dis VL - 33 UR - https://doi.org/10.1086/322710 DO - 10.1086/322710 ID - Casadevall2001 ER - TY - JOUR AU - Romani, L. PY - 2011 DA - 2011// TI - Immunity to fungal infections JO - Nat Rev Immunol VL - 11 UR - https://doi.org/10.1038/nri2939 DO - 10.1038/nri2939 ID - Romani2011 ER - TY - CHAP AU - Hawker, F. ED - Park, G. ED - Shelly, M. PY - 2001 DA - 2001// TI - Hepatic failure BT - Pharmacology of the Critically Ill:Fundamentals of Anaesthesia and Acute Medicine PB - BMJ Books CY - London ID - Hawker2001 ER -